Nypozi Injection
Product Images NDC 72374-101

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Nypozi (NDC 72374-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tanvex Biopharma Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Nypozi 01)

This text appears to be a description of a medical device, likely a syringe or injection tool. It provides a guide on the various components of the device including the viewing window, needle cap, finger grips, plunger, dose markings, plunger stopper, expiration date label, and instructions for use before and after. The text seems to emphasize the importance of safely using and handling the medical tool.*

FDA Label Image

Image (Nypozi 02)

This text is not available.*

FDA Label Image

Image (Nypozi 03)

FDA Label Image

Image (Nypozi 04)

FDA Label Image

Image (Nypozi 05)

This text mentions alcohol wipe, adhesive bandage, and disposal container. It seems to be a list of items that might be part of a first aid kit or medical supplies.*

FDA Label Image

Image (Nypozi 06)

FDA Label Image

Image (Nypozi 07)

FDA Label Image

Image (Nypozi 08)

FDA Label Image

Image (Nypozi 09)

FDA Label Image

Image (Nypozi 10)

This text provides step-by-step instructions for using a medical device, specifically detailing the initial position and adjustments associated with setting a partial dose. It highlights the alignment of the top edge of the conical base of the plunger stopper with the dose.*

FDA Label Image

Image (Nypozi 11)

FDA Label Image

Image (Nypozi 12)

FDA Label Image

Image (Nypozi 13)

FDA Label Image

Image (Nypozi 14)

FDA Label Image

Image (Nypozi 15)

FDA Label Image

Image (Nypozi 16)

FDA Label Image

Image (Nypozi 17)

FDA Label Image

Principal Display Panel ((1) 0.5 mL Syringe Carton)

This text provides information about NYPOZI™ (filgrastim-txid) injection in a Single-Dose Prefilled Syringe, with a concentration of 300 mcg/0.5 mL. It is a Recombinant Granulocyte Colony Stimulating Factor (G-CSF) derived from E. Coli, intended for subcutaneous or intravenous use. Instructions include dilution guidelines for intravenous administration and advice on discarding any unused portion of the syringe. The text also mentions specific storage conditions and safety instructions for keeping the drug out of reach of children. Additionally, it provides a US License No. 2259 and dosage information.*

FDA Label Image

Principal Display Panel ((10) 0.5 mL Syringe Carton)

This is information about NYPOZI™ Single-Dose Prefilled Syringe containing filgrastim-txid injection in 300 mcg/0.5 mL dosage. It is a recombinant granulocyte colony-stimulating factor derived from E Coli for subcutaneous or intravenous use. The syringe comes with a needle guard, and if required for intravenous administration, it should be diluted in a 5% Dextrose Injection solution. The product is free from latex and preservatives and should be stored refrigerated at 2°C to 8°C. The syringe contains specific ingredients and should not be frozen or shaken. It is essential to keep this medication out of reach of children and refer to prescribing information for dosage details. Manufactured by Tanvex BioPharma USA, Inc.*

FDA Label Image

Principal Display Panel ((1) 0.5 mL Syringe Carton)

This text is a description of a medication called filgrastim-txid injection, available in a prefilled syringe with a needle guard. It contains 480 mcg/0.8 mL of a recombinant Granulocyte Colony Stimulating Factor (G-CSF) derived from E. Coli. The medication is intended for subcutaneous or intravenous use. For intravenous administration, it should be diluted in 5% Dextrose Injection. The syringe is labeled with the brand name NYPOZI™ and should be discarded after single use. Additional instructions are provided for protecting the medication from absorption to plastic materials. The text also mentions the inclusion of Albumin (Human) to a final concentration of 2 mg/mL. Further details include dosage information and a US License number.*

FDA Label Image

Principal Display Panel ((10) 0.5 mL Syringe Carton)

NYPOZI™ Single-Dose Prefilled Syringe (filgrastim-txid) is a medication used for subcutaneous or intravenous use. It is a recombinant Granulocyte Colony Stimulating Factor (G-CSF) derived from E. Coli. Each prefilled syringe contains 480 mcg of filgrastim-txid along with other ingredients. It is important to dilute the medication if required for intravenous administration and to store it refrigerated between 2°C to 8°C. This product is preservative-free and does not contain latex. The packaging comes with a needle guard for safety. It is essential to follow the prescribed dosage and handling instructions provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.